All Stories

  1. Targeting senescent cholangiocytes and activated fibroblasts with Bcl-xL inhibitors ameliorates fibrosis in Mdr2-/- mice

    Article • Hepatology, August 2017, Wiley

    Anja Moncsek, Christian Fingas

  2. Polo-like kinase 3 is associated with improved overall survival in cholangiocarcinoma

    Article • Liver International, April 2015, Wiley

    Christian Fingas